Fermenters Market By Product Type (Single-use fermenters, Stainless steel fermenters, Glass fermenters), By Application (Food & Beverage Industry, Pharmaceutical & Biotech Industry, Academic & Research Institutes, Chemical Industry, Others), By Operation Mode (Batch fermentation, Fed-batch fermentation, Continuous fermentation), By End-user (Biopharmaceutical companies, Contract manufacturing organizations, Research laboratories, Food & beverage companies, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

What trends will shape the Fermenters Market in the coming years?

The Fermenters Market accounted for USD 1.97 Billion in 2024 and USD 2.14 Billion in 2025 is expected to reach USD 4.8 Billion by 2035, growing at a CAGR of around 8.51% between 2025 and 2035. The Fermenters Market deals with equipment in the fields of microbial fermentation in biotechnology, pharmaceuticals, food & beverages, and industrial processes. The vessels are used to ensure the growth and multiplication of microorganisms are controlled to produce antibiotics, enzymes, vaccines, alcohol, and biofuels.

Among the trends that are influencing this market are increased demand for biopharmaceuticals, fermented foods, and food products, including products made of plants, and sustainability in biomanufacturing. Improvements in single-user fermenters, automation, and scale of production are increasing uptake. The market will continue growing in the future as more funds are invested in synthetic biology, personalized medicine, and clean energy options. 

What do industry experts say about the Fermenters Market trends?

"Fermentors are the backbone of industrial biotechnology, enabling scalable and reproducible cultivation of microorganisms for applications ranging from antibiotics to biofuels."

• Dr. James Liao, Professor of Chemical and Biomolecular Engineering, UCLA.

Which segments and geographies does the report analyze?

What are the key drivers and challenges shaping the Fermenters Market?

How is rising biopharmaceutical demand boosting fermenter equipment adoption globally?

The Fermenters Market is enjoying strong growth due to the growing demand for biopharmaceuticals in the world. With the transformation in the industry as we move away to a synthetic chemical industry, where we now have biologics: monoclonal antibodies, recombinant proteins, and cell-based therapy, various products, the stakes on advanced fermentation systems are now more critical than ever. These fermenters provide accurate temperature control, pH control, aeration control, and agitation control, the requirements of maximum yield, and control of the product used. Specifically, increased interest of biopharma companies in scalable bioprocessing equipment is observed in post-pandemic healthcare environments, where biopharma entities work hard to supply the entire world with therapeutics.

Besides, the deployment of fermentation infrastructure is being boosted by government incentives and the fast-track of drug approvals of biologics. This trend will be an opportunity for the Fermenters Market as biomanufacturers are interested in increasing their production capacity and fulfilling their regulatory compliance and cost requirements. The demand for equipment is also being boosted by the large-scale production of biosimilars in emerging markets. The flexible growth in fermenter capacity through contract manufacturing organizations (CMOs) is also feeding growth, as can be seen in the global fermentation-derived product capacity levels, which have gone past ~16 million liters with 48 known fermentation producers and 41 food-only CMOs contributing to this growing infrastructure to support a growing number of fermentation applications.

Why does plant-based food fermentation drive uptake in food industries?

Fermenters Market has immense potential openings because of consumer interest in plant-based foods and functional foods, namely in the food and beverage sector. The growth in popularity of plant-based milk, fermented protein food, and gut-health supplements, such as kombucha and tempeh, is increasing the demand for small- to mid-scale fermenters to fit food-grade operations. The food businesses are also taking advantage of fermentation beyond shelf-life and flavor enhancement to add probiotics and nutrition concerns. Fermentation is ideal in food-tech, future-proofing new product development using clean-label, sustainable, and innovative products. As plant-based product launches continue to quicken throughout the world, food processors have become aggressive in the use of fermenters in research and development, as well as manufacturing processes.

With this trend, the Fermenters Market will likely be characterized by an increase in the adoption by both established food brands as well as new plant-based companies. Next-gen plant-based textures and flavors are also permitted through innovations of microbial strains and precision fermentation. To give momentum, a survey of microbial bioreactors around the globe returned ~1,800 systems 100 L and larger, with nearly 500 systems 2000 L and up, illustrating both that the space has already committed to microbial (and food grade) fermentation at scale, and to demonstrate that there is a lot of active space on the scale of the 1,000 L-10,000 L envisioned by the early pioneers of the space.

Why are high initial investments a barrier for small manufacturers?

Along with its enormous potential, Fermenters Market has one major weakness, i.e., excessive capital expenditure. The initial investment that comes with buying and installing fermenters, especially those made of stainless steel or automated ones, is so high that it may be unaffordable to smaller and medium-sized manufacturers. These expenses do not only concern the equipment itself but additionally the necessity of auxiliary systems (e.g., sterilization units, sensors, software), upgrading the facilities, and maintaining the device.

Such financial barriers increasingly hold up the scale-up exercise and deny many startups and contract manufacturing units entrance into advanced forms of bioprocessing. Also, risk-averse stakeholders are deterred by the long periods to recover the investment (return on investment, ROI). Consequently, the penetration of these technologies may take longer in the Fermenters Market, whereas the bigger corporations find it easier to adhere to these technologies. Leasing models and the public-private partnership could prevent this difficulty to some extent in the case of sufficient expansion. Nevertheless, in underdeveloped regions, the consciousness about such sources of financing and their availability is very low.

How can synthetic biology innovations create demand for custom fermenters?

The introduction of synthetic biology is re-shaping the definitions of biological manufacturing, and this is posing a huge opportunity to the Fermenters Market. Synthetic biology works towards the design and engineering of new biological functions or organisms to serve specific purposes, such as bio-based plastics to grow meat in the laboratory, and engineering microbes. The new biological entities usually demand special fermentation conditions, going against ordinary systems. The new requirement is spawning a new market of specially-developed fermenters that are precise enough, modular, and capable of high-throughput screening.

The pressure on next-gen fermenters that can sustain dynamic and complex workflows has already been observed as the research institutions and startups continue to explore synthetic biology further. The Fermentators market is ready to leverage this momentum, given its ability to present adaptable and scalable solutions that are aligned with bio-fabrication that is future-proof. They will have to rely on cross-sector partnerships between biotech companies and equipment manufacturers to bring these bespoke solutions to bear. New Asia-Pacific and European technologies have already got early-stage deployments.

Why is growth in personalized medicine opening biotech fermentation markets?

The growing demand for personalized medicine is opening up new avenues of growth in the Fermenters Market, particularly in the biopharmaceutical sector. With more patient-specific therapy, be it custom biologics, gene-based therapies, or even cell-based therapies, the manufacturing process also needs to change to flexible, small-lot production. Particularly, in single-use or modular fermenters, the situation is becoming essential because of the need to design and manufacture drugs with high purity and individualized treatment within firm schedules and regulatory guidelines.

Such systems make the changeovers fast and minimize the risk of cross-contamination, which is essential to the personalized therapy workflow. These capabilities are being invested in by the healthcare systems of the world at an increasing rate, and biotech companies are restructuring their infrastructure to address the changing needs. The Fermenters Market will benefit in such a setting as a strategic facilitator of manufacturing personalized treatment. Such a tendency corresponds to the emergence of decentralized and point-of-care manufacturing units. This has led to an increased push in demand for compact, plug-and-play fermenters.

What are the key market segments in the Fermenters industry?

Based on the Product Type, the Fermenters Market has been classified into Single-use fermenters, Stainless steel fermenters, and Glass fermenters. Stainless steel fermenters have so far taken the lead in this market by their durable nature, reusability, and the ability to be used in large-scale bioprocessing, particularly in the pharmaceutical and industrial environments. Single-use fermenters are, however, gaining popularity notably in biological and clinical research work, and the biologic products with smaller batches since they require fewer contaminations, consume less time to clean, and have quicker turnaround.

Glass fermenters, although small-scale in nature, are common in academic and research, and development environments due to visibility and the ease with which they can be experimented with. The market is experiencing a slow transition to hybrid systems as the regulatory standards require more thorough regulation, and manufacturing agility competes with other businesses. 

Based on the Application, the Fermenters Market has been classified into the Food & Beverage Industry, Pharmaceutical & Biotech Industry, Academic & Research Institutes, Chemical Industry, and Others. The pharmaceutical and biotech industry is highlighted as the main area of the Fermenters Market, as the increasing demand, vaccine production, and cell-based treatment take the field.

The fermentation industries to which these solutions are applied must be high precision, sterile, and scalable, thus making both the innovation and volume drivers. The food and beverage industry closely trails owing to the thriving industry of plant-based, fermented, and probiotic sectors. In the interim, academic and research centers are using the miniature or bench-scale in terms of fermenters to facilitate R&D programs, whereas, in the chemical industry, fermentation is utilized in the production of bio-based materials, enzymes, and organic acids.     

Which regions are leading the Fermenters Market, and why?

North America Fermenters Market holds the largest share, as this market is supported by a mature biopharmaceutical industry, developed healthcare infrastructure, and intensive R&D spending. Several large biotech companies, CMOs, and academic organizations in the U.S. (in particular) invest continuously in the development of technologies in the fermentation of biologics, vaccines, and precision medicine.

Biologics, stable demand for novel treatments, as well as regulatory support, cause the deployment of fermenters across the region, too. Also, a high number of combined international manufacturers and suppliers of fermenters and features further contributes to the success of the North American market. North America is leading the pack in both the adoption rate and the level of technological advancement of fermentation systems in this environment.

The Asia-Pacific Fermenters Market is the fastest-growing due to rapid industrialization, more pharmaceutical production, and demand for low-cost biologics. The infrastructural investments in biotech seem to be booming in countries such as China, India, and South Korea due to government incentives and international ties.

Additionally, there is a growth in food processing, fermentation-based production within the economies, and this is increasing the demand for automated equipment within these industries. Due to the low-cost talent pool, escalating health consciousness, and transitioning to eco-friendly production, the Asia-Pacific is soon emerging as a global center of scalable fermentation applications. With this pick up, the region is set to take the centre stage in determining the future of the Fermenters Market.  

What does the competitive landscape of the Fermenters Market look like?

The Fermenters Market competitive environment can be characterized by the presence of a combination of large-scale bio-processing industry players and equipment-specific suppliers engaged in a rivalry to achieve the increase of scalability, automation, and customization. Notable market competitors are Sartorius AG, Thermo Fisher Scientific, Eppendorf AG, Applikon Biotechnology, GEA Group, Solaris Biotech, Bioengineering AG, and Pierre Guerin. Such companies are aiming at growth in the global presence as a way of attacking mergers, acquisitions, and merger-like interactions with the biopharma firms and CMOs. The tendency to provide complete bioprocessing solutions with the use of single-use systems and digital control systems is remarkable because it enhances efficiency and compliance.

To achieve a modular design, embedded IoT, and enhanced process control, many players are going into massive R&D spending in order to devise fermenters. Application-specific customization, be it to biologics, food, or flavor chemicals, is becoming a major differentiator. In the meantime, Asia-Pacific market growth plans are also on the rise, and companies have established their manufacturing and service centres in the region to capitalise on the increasing demand in the region. The ability to be innovative, provide technical support, and flexibility in pricing will remain the hallmarks of market leadership in the fermenters segment as the level of competition rises.

Fermenters Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Sample Report

Which recent mergers, acquisitions, or product launches are shaping the Fermenters industry?

• In April 2025, AGC Biologics announced it would install two 5,000 L Thermo Scientific DynaDrive single‑use bioreactors at its new facility in Yokohama, Japan, positioning the site among the most advanced for large-scale biologics production in the country, with GMP operations planned for 2027.
• In June 2025, Sartorius hosted its PI Forum in Boston, focusing on process intensification strategies for protein therapeutics and emerging modalities, including biomanufacturing digitalization and flexible systems

Report Coverage:

By Product Type

• Single-use fermenters
• Stainless steel fermenters
• Glass fermenters

By Application

• Food & Beverage Industry
• Pharmaceutical & Biotech Industry
• Academic & Research Institutes
• Chemical Industry
• Others

By Operation Mode

• Batch fermentation
• Fed-batch fermentation
• Continuous fermentation

By End-user

• Biopharmaceutical companies
• Contract manufacturing organization
• Research laboratories
• Food & beverage companies
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Sartorius AG
• Eppendorf AG
• Thermo Fisher Scientific
• Pierre Guerin SAS
• Applikon Biotechnology BV
• Bioengineering AG
• DIOSNA Dierks & Söhne GmbH
• SYSBIOTECH GmbH
• CETOTEC GmbH
• GEA Group
• Solaris Biotech
• Electrolab Biotech
• CerCell ApS
• New Brunswick Scientific Co.
• Zeta Holding GmbH

Frequently Asked Questions (FAQs)